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Abstract 
Random peptide libraries that cover large search spaces are often used for the discovery of new binders, even when 
the target is unknown. To ensure an accurate population representation, there is a tendency to use large libraries. 
However, parameters such as the synthesis scale, the number of library members, the sequence deconvolution and 
peptide structure elucidation, are challenging when increasing the library size. To tackle these challenges, we pro-
pose an algorithm-supported approach to peptide library design based on molecular mass and amino acid diversity. 
The aim is to simplify the tedious permutation identification in complex mixtures, when mass spectrometry is used, 
by avoiding mass redundancy. For this purpose, we applied multi (two- and three-)-objective genetic algorithms to 
discriminate between library members based on defined parameters. The optimizations led to diverse random librar-
ies by maximizing the number of amino acid permutations and minimizing the mass and/or sequence overlapping. 
The algorithm-suggested designs offer to the user a choice of appropriate compromise solutions depending on the 
experimental needs. This implies that diversity rather than library size is the key element when designing peptide 
libraries for the discovery of potential novel biologically active peptides.
Keywords: Peptide libraries, One-bead-one-compound, Algorithm-supported design, Genetic algorithm, 
Optimization
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Introduction
Small-molecule libraries are widely used in drug dis-
covery to identify biologically active molecules [1]. Tra-
ditionally, small molecule library design is based on a 
known target structure or on known ligands. The last two 
decades have witnessed the application of docking calcu-
lations to the pharmaceutical field through the lead opti-
mization of structure-based design of small molecules 
[2]. Moreover, molecular docking is the main approach 
in the structure-based peptidyl-drug design studies, even 
though peptide based drugs are less explored than the 
small molecule ones. However, when the targets and/
or ligands are unknown or “undruggable” this virtual 
screening approach fails to provide useful information 
[3]. Therefore, one has to rely on experimental screen-
ings of random, large numbers of compounds in order to 
obtain further insight into possible identification of bind-
ers or disruptors of protein-protein interactions (PPI) [4, 
5].
Safer and more specific alternatives to small molecules, 
peptide-based drugs are emerging as a new paradigm in 
medicinal chemistry [6, 7]. Therefore, there is a need to 
develop combinatorial approaches to identify new pep-
tide therapeutics [5]. In this context, phage display was 
the main approach to obtain a variety of random peptide 
sequences [8, 9]. Nowadays, the phage display technol-
ogy is well established in the peptide-based drug discov-
ery process [10, 11]. However, the limitation was that the 
library building blocks are limited to the 20 natural pro-
teinogenic amino acids resulting in peptides with short 
half-lives and susceptible to proteolytic cleavage. Pro-
gress with phage display and RNA-display technologies 
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has allowed the use of non-proteinogenic amino acids in 
those techniques [12], but the one-bead-one-compound 
(OBOC) method allows a more straightforward use of 
unnatural amino acids [13, 14]. It allows the introduction 
of stereochemical variability at the α-carbon, head-to-tail 
cyclization, disulfide bridges, etc. and their combinations 
without complex genetic manipulations [15]. Therefore, 
OBOC peptide libraries, have opened up the path to a 
larger search space for discovery of peptide-based drugs 
[15, 16].
Chemical and molecular diversity of library compo-
nents are key for drug discovery [17]. Combinatorial 
libraries are tools that allow large amount of compounds 
to be screened at the same time [4]. Currently, the diver-
sity-oriented systems (DOS) for small molecules are tak-
ing over the static combinatorial approach, allowing the 
introduction of skeletal, structural and stereo-chemical 
complexity [18–20]. Similarly to DOS, one can think of 
introducing stereo-chemical and skeletal complexity into 
peptides through the use of D-stereoisomers, the com-
bination of L- and D-ones, the retro-enantio versions 
and cyclization. By this means, peptide-based libraries 
with increased stability could be generated. However, 
their analysis is challenging as similarity in structure and 
behavior of available peptide permutations would lead to 
the impossibility to distinguish between sequences using 
today’s available screening and/or analyzing techniques 
such as HPLC, UPLC-MS, etc.
It is believed that larger the sample size, more accu-
rate is the representation of a given population [21]. In 
these terms, random libraries are advantageous over the 
focused ones, as they cover a larger search space. How-
ever, parameters such as the synthesis scale to guarantee 
the synthesis of all possible compounds, the number of 
library members, the sequence deconvolution and pep-
tide structure elucidation after screening, are challeng-
ing steps when increasing the library size [22]. Moreover, 
libraries may result in competition among candidates 
and biased hits identification due to the physico-chemi-
cal similarity of the components [21]. This is particularly 
the case during the sequence deconvolution process of 
positive hits, where the identification of single peptides 
is not always possible. Often, families of peptides having 
identical masses are identified [23]. In order to address 
this issue, we set out to determine whether multi-objec-
tive genetic algorithms can aid and simplify the rational 
design of random libraries to increase diversity and 
minimize redundancy. The advantage of this tool is the 
reduction of the number of library members in a single 
screening while maintaining maximal chemical and mass 
diversity.
Recently, artificial intelligence has been applied to a 
variety of chemical problems to maximize the chance of 
successful and rapid solving of complex issues [24–28]. 
In our group, evolutionary algorithms have been suc-
cessfully applied to address various challenges of peptide 
chemistry [29–32] related to the design and identifica-
tion of peptides that cross the blood-brain-barrier (BBB) 
[33], or that bind to the major histocompatibility com-
plex (MHC) [34]. Recently, Cronin and co-workers used 
evolutionary algorithms in combination to machine 
learning to predict antimicrobial activity of peptide 
sequences [35]. Although the heuristic approach has 
been explored in the field of peptide design, it is mainly 
focused on the use of the one-objective setting where 
one fitness function optimizes a specific peptide property 
(e.g., antimicrobial, anticancer activity) [36–38]. To date, 
multi-objective genetic algorithms have been applied to 
the design of small molecule combinatorial libraries [21, 
39–41] but have not been explored for random peptide 
libraries yet. Herein, we present the framework to solving 
and/or simplifying a combinatorial challenge—whether 
we could rationally design a random peptide library and 
what are the rules that underline this algorithm sup-
ported process. For this purpose, we used an evolution-
ary computing approach based on a multi-objective 
genetic algorithm (GA) [42, 43] represented in scheme 1 
to address the issue of maximizing the number of diverse 
amino acid permutations. In this way, sequence deconvo-
lution and peptide sequence elucidation are simplified by 
avoiding sequence redundancy. Ultimately, the designer 
is able to make an algorithm-supported choice of an 
appropriate compromise solution among given  opti-
mized library designs, depending on the experimental 
needs.
Results and discussion
The 20 gene-encoded amino acids, together with a vari-
ety of non-natural ones, constitute a versatile toolbox for 
combinatorial library design (Scheme 1a). A high chemi-
cal and structural diversity can be achieved by designing 
libraries composed of sequences of amino acids (pep-
tides) which total number is calculated using the for-
mula R = mr , where r is the number of positions where 
the variability can be introduced and m the number of 
amino acids per position [22]. Therefore, the number 
of permutations grows exponentially with the peptide 
length, depending also on the number of amino acids per 
position. If all the 20 proteinogenic amino acids are used 
in r positions, there are R = 20r possible permutations. 
OBOC libraries prepared using the “split and mix” meth-
odology result in redundant peptide mixtures consist-
ing of permutations of amino acids having overlapping 
masses [23].
In our study, the introduction of complexity of the 
system refers to the molecular weight ( MW  ) diversity of 
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the library components. In the case of peptides, made of 
combinations of various natural or non-natural amino 
acids, the MW  diversity often corresponds to sequence 
diversity. Therefore, based on monoisotopic MW  values 
we set out to determine an algorithm supported approach 
to help the random design of systems that maintain max-
imum mass and sequence diversity. Ultimately, the objec-
tive of this paper is to simplify the tedious and sometimes 
difficult chromatographic and mass spectrometry based 
analyses of complex mixtures of peptides that have simi-
lar properties. We chose the MW  as the discriminant for 
increasing diversity and complexity of the system, conse-
quently reducing the number of peptides in the mixture.
First, we developed a peptide mass calculator with 
the possibility to discriminate between masses of 
peptides in a given mixture, generating an output csv 
Scheme 1 Towards the algorithm-supported design of random peptide libraries. a Amino acid toolbox of L- and D-stereoisomers of 20 
proteinogenic amino acids color-coded to represent a specific property: hydrophobic-aromatic (magenta), hydrophobic-aliphatic (blue), 
hydrophilic-uncharged (purple), hydrophilic-positively charged (green), and hydrophilic-negatively charged (orange). b Graphical representation 
of building an OBOC peptide library, based on dipeptides (r = 2), using the representative amino acids from the toolbox (m = 5), depicting the 
advantage of working with sequences having unique masses. The calculator explores the full sequence space ( 52 = 25 ) and excludes permutations 
that present the same mass and differ only in the amino acid order within the sequence. c Schematic representation of the 2-objective genetic 
algorithm used to perform the optimization, indicating the steps required to perform the selection of individuals for the next generation. The main 
criteria of the GA are two fitness functions for maximizing (1) the number of all amino acid permutations and (2) the number of sequences having 
unique mass. d Schematic representation of the optimization algorithm input and outputs suggesting the best design options (for each position r) 
to obtain maximally diverse random peptide libraries
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(comma-separated values) file containing all possible 
peptide permutations alongside with their masses in 
addition to a csv file containing the list of peptides with 
unique masses. In the latter, the permutations hav-
ing the same amino acid composition but with vary-
ing locations within the sequence were omitted except 
one representative of each collision set. The same was 
applied to peptides having different amino acid com-
position but overlapping masses, with tolerance set to 
1 (see Additional file  1: Fig. S7). Tolerance is an arbi-
trary parameter that is user defined and it can be tuned 
to any value, as described in the next subsection. A 
simplified schematic representation of the calculator 
output, using a small library of dipeptides is shown in 
Scheme  1b. The amino acids are divided in 5 different 
categories (color-coded) depending on their polarity 
and charge (Scheme  1a). If each of the colors stands 
for one representative amino acid and all the possible 
dipeptides are made, there are 52 (r = 2, m = 5) = 25 
permutations. After the calculator excludes the pep-
tides with overlapping masses, we are left with a sub-
set of 15 dipeptides of unique masses, as shown in 
Scheme 1b (right panel). In this way, we could simplify 
the chromatographic and mass spectrometry analysis 
of the mixture.
The following step was the development of the optimi-
zation tool based on the genetic algorithm (Scheme  1c) 
that is able to suggest several design strategies based on 
user’s needs and inputs (Scheme  1d). The input is the 
same as for the calculator, where the number of posi-
tions (r) and the amino acids ( xi ) for each position have 
to be defined. The output is a Pareto front containing a 
distribution of solutions, based on how they scored dur-
ing the GA selection rounds. The Pareto front is a set of 
non-dominated solutions chosen as optimal by the GA. 
Subsequently, the user makes the choice of the preferred 
design suggestion based on the experimental expertise 
and the requirements of the library (Scheme  1d). We 
refer to this choice as algorithm-supported decision. 
Moreover, we explored the possibility of a three objective 
algorithm to include also the sequence diversity.
Library mass analysis with the combinatorial calculator
During the initial step of peptide library planning there 
are two parameters that need to be determined (Fig. 1a): 
(1) the number of positions r and (2) the list of mi amino 
acids xi = {} that can appear at i-th positions, where 
1 ≤ i ≤ r . These constitute our input parameters. To sim-
plify and automatize mass calculations of all the possible 
permutations in a user-defined peptide library, the pep-
tide mass calculator algorithm was developed using the 
Matlab scripting language. An example is a pentapeptide 
library where the input was: r = 5, m = 6, for xi = s, e, r, 
w, a, G (Fig. 1a). For this condition, the total number of 
peptide permutations given by mr is 7776 (Fig. 1b).
The peptide mass calculator also compares the masses 
of all the possible permutations and locates the ones 
that have unique mass. The motivation behind this 
was to estimate whether the analysis of all the com-
pounds with unique masses i.e., simplified libraries in 
terms of number of peptides in the mixture is feasi-
ble by using chromatography coupled mass spectrom-
etry. Hence, the mass of a peptide M is considered 
unique if no other peptide has the mass within the range 
< M − T (�mass),M + T (�mass) > . If there is another 
peptide in the mixture, having mass within this range, it 
is excluded from the list of permutations unique by mass, 
thus automatizing redundancy identification. The param-
eter T (�mass) is referred to as the tolerance of mass dis-
crimination. It is also a user-defined parameter, which 
may be tuned (according to user’s needs and the resolu-
tion of the machine used to perform the mass spectrome-
try). Throughout this study, the condition T (�mass) = 1 
was kept in all the calculations and permutations, unless 
Fig. 1 Peptide calculator inputs and outputs. a Summary of the input to the peptide mass calculator indicating the number of positions (r = 5) 
where variability can be introduced and the possible amino acids for each position (m = 6; being xi = s, e, r ,w , a,G ) and T (�mass) = 1 . b List of 
outputs of the peptide mass calculator showing the theoretical number of possible permutations (= 7776) and the number of permutations having 
unique masses (= 130) alongside their list. c A screenshot of a part of the output file in the csv format
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stated otherwise. Using this configuration and the exem-
plary pentapeptide library from Fig.  1a, the peptide 
mass calculator computes 130 peptides of unique mass 
(Fig. 1b).
The calculator output provides a csv (comma-sep-
arated value) type file containing the full list of permu-
tations with the corresponding MW  values, in the form 
of: (1) the average mass, (2) the monoisotopic mass, (3) 
the singly charged [M +H ]+ and (4) the doubly charged 
[M + 2H ]2+ expected ions for mass spectrometry analy-
sis (Fig.  1c). The algorithm also provides the full list of 
unique peptide masses (for simplicity only a screenshot is 
shown in the Fig. 1c).
Therefore, our algorithm gives the possibility to the 
user to explore all possible permutations as well as the 
ones baring unique masses, representative of the popu-
lation. Here, peptide diversity is achieved solely through 
the introduction of functional group (side chain) diver-
sity and leads to peptide collections with variable mass 
diversity. This tool is the basis for the optimization pro-
cess used for the algorithm-supported library design 
described below.
Library design optimization with the genetic algorithm 
approach
Next, we developed an optimization decision support 
system based on the genetic algorithm (GA) approach. 
GAs are iterative heuristic processes of computational 
optimization that is based on selection, cross-over and 
mutation of genes, analogous to the natural process 
of evolution where the best genes of individuals are 
preserved and passed to the next generation with the 
expectation that the fittest parents will give even fitter 
offspring. In computer science, GAs are mimicking this 
process by trial and error, gradually finding the best solu-
tion or solutions to a given problem and ending only if 
one of the stopping criteria is met (Fig. 1c): (1) the fitness 
function of an individual achieved the maximum level or 
a predefined threshold level, i.e., the algorithm has found 
the best solution or a solution that is good enough; (2) 
after a certain number of generations, the fitness func-
tion of best solutions is not improved, i.e., the algorithm 
cannot find another solution that is better than the one it 
has already found. In each iteration (generation) of a GA, 
a group (population) of candidate solutions (individuals) 
to a given optimization problem are considered simulta-
neously. Each solution is defined by parameters encoded 
in genes and its quality is quantified by fitness functions. 
The values of fitness functions are numerical indicators 
used to compare solutions and find the best ones.
In this paper, the second variant of the Non-dominated 
Solutions Genetic Algorithm (NSGA-II) was used to run 
peptide library optimizations. The goal was to identify 
optimal library designs that yield the greatest number of 
peptides with unique masses. The motivation was to find 
library designs with feasible analysis of all its components 
by chromatography coupled mass spectrometry. The 
design of a library is defined by the number of positions r 
and the variability (a number of possible amino acids) in 
each position xi (1 < i < r) . The variability is user defined 
and consists of a set of possible amino acids, which may 
vary for each position. The implemented algorithm trans-
forms each set of possible amino acids into a bit-string, 
where the length of the bit-string is equal to the length 
of the set and each bit (1 or 0) represents the inclusion 
(1) or exclusion (0) of a given amino acid. That way, the 
algorithm is searching for an optimal subset of amino 
acids. The search is guided by two fitness functions that 
need to be maximized: (1) the total number of peptides 
for a given variability and (2) the number of peptides 
unique by mass. Both fitness functions are computed for 
each solution examined in this iterative search process by 
using the peptide mass calculator.
To illustrate the advantage of the optimization output 
over the single, user-predetermined design, we used the 
same input shown in Fig.  1a. In contrast to the peptide 
calculator, the optimization offers a wide range of ran-
dom peptide library designs simplified to satisfy the max-
imum mass diversity condition. This can be seen from the 
Pareto front that contains all the best solutions (red dots) 
and the distribution of all the remaining solutions from 
the final population (blue dots) in Fig. 2. We focused our 
analysis to the 70% to 100% diversity region and reported 
on the three best solutions encircled in the zoomed 
Pareto front graph being BS 1 (100%), BS 2 (94%) and BS 
3 (92%). Our implementation of the algorithm also allows 
the user to pick any point of interest and obtain a detailed 
analysis containing the output of the peptide mass calcu-
lator accompanied by the corresponding sequence logo 
graphs. All the sequence logos throughout the text are 
presented in the conventional N- to C-terminus fashion.
The library design suggestion for BS 1 consists of 32 
peptides having unique mass. The algorithm informs 
that this specific library can be obtained by simpli-
fying the input from s, e, r, w, a, G in each position  xi 
to {a, G} for x1 , {w, a} for x2 , {r, G} for x3 , {e, r} for x4 
and {s, r} for x5 (Fig. 2). Similar design suggestions are 
shown in Fig.  2 for BS 2 and BS 3, where the number 
of peptides having unique masses increases as well as 
the mass overlapping. Depending on users require-
ments, in terms of the number of library members and 
the desired chemical diversity, the design strategy can 
shift towards the increasing number of possible peptide 
permutations and introduction of limited or extended 
mass overlapping. From the same optimization, BS 
50%, BS 30% and BS 10% points were also analyzed. 
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The zoom of the Pareto front in the 10% to 50% mass 
diversity range with the corresponding sequence logos 
can be found in supplementary information (Additional 
file 1: Fig. S1). Having increased the number of amino 
acids in each position xi lead to the greater number 
of peptides unique by mass in BS 50%, BS 30% and BS 
10%. However, the total number of peptides increased 
at a greater rate, thus reducing the overall mass diver-
sity ratio of these libraries.
The size of search space is the number of all possible 
solutions for the binary encoded genome calculated as 
2(r∗m) (Fig.  3a). In our case, the complexity of the opti-
mization task is determined by the search space size that 
is exponentially dependent on the product of m and r. In 
Fig. 3, we showed how the search space changes from 109 
Fig. 2 Genetic algorithm-informed design suggestions. Output of the optimization genetic algorithm used to identify the best library designs, 
showing the pareto front (and the zoom of the 70–100% variability region of the pareto front) with all the working solutions (blue) and the 
best solutions (red) from the final population, obtained using the same input as in Fig. 1a. Three representative solutions (BS 1, BS 2 and BS 3 
corresponding to 100%, 94% and 92% respectively) have been selected as suggestions for three possible designs to obtain “simplified” and 
maximally diverse OBOC libraries
Fig. 3 Optimization of an exemplary multi-peptide library (T( mass)=1). a Input for the optimization genetic algorithm indicating the varying 
number of positions r, the number of theoretical permutations n, the size of search space, and the number of peptides in the BS 1 for each r. b 
The rate of change of the search space, presented in logarithmic scale (x-axis) in comparison to the exponential growth of the total number of 
permutation (y-axis). c Sequence logos of BS 1, where the percentage of peptides diverse by mass is 100%
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to 1016 for a constant value of m ( m = 6 ) when increasing 
r from 5 to 10, respectively. The time needed to complete 
the optimization task is influenced by its complexity (i.e. 
balance of m and r) and the available computer resources. 
For peptide lengths from 5 to 10-residues long with vary-
ing values of m the algorithm completed the optimiza-
tion tasks in a reasonable time frame (hours to days) with 
a standard PC configuration. In contrast to the search 
space complexity for the given set of libraries (Fig.  3b), 
all the best solutions (BS 1) have only 32 peptides unique 
by mass, regardless of the increasing number of posi-
tions r (Fig. 3a). A set of sequence logo graphs given in 
Fig. 3c corresponding to 100% mass diversity shows a set 
of designs available to the user. Their similarity proves 
that having an algorithm-supported design strategy still 
requires carefully chosen inputs from the expert user.
To illustrate the utility of the two-objective optimiza-
tion, we used the example of an all D-heptapeptide with r 
= 5 and m = 7, for xi = s, e, r,w, a,G, i ; having two fixed 
positions x3 = p and x7 = y . The Pareto front for this 
optimization can be seen in Fig. 4a. When zoomed into 
the 70–100% mass diversity region, several design solu-
tions appear. We chose to analyze five points being BS 
1 (100%), BS 2 (98%), BS 3 (86%), BS 4 (77%) and BS 6 
(70%) and show their sequence logos (Fig.  4b and c) to 
allow better visualization of the design suggestions and 
possible synthetic challenges. In our region of interest, 
the algorithm suggests possible designs to obtain maxi-
mally diverse random peptide libraries. Interestingly, BS 
2 shows a high mass diversity of 98% and only one pep-
tide with overlapping mass. With 47 peptides unique by 
mass it offers a design possibility with 33% higher total 
number of peptides and only 2% mass diversity reduction 
when compared to BS 1. Thus, this would be our design 
of choice to attempt the experimental validation. The 
complete list of peptides for this solution can be found in 
the Additional file 2: Table S1.
To show the versatility of the optimization process, we 
presented several other examples of library designs: (a) 
r = 5, m = 6 for xi = s, e, r,w, a,G ; x6 = y in Additional 
file  1: Fig. S2, (b) r = 7, m = 7 for xi = w, r, e, p, s, i, a ; 
x7 = y in Additional file 1: Fig. S3, (c) r = 5, m = 10 for 
xi = h, f , r, a, n, e, s, y,w, i in Additional file 1: Fig. S4 and 
(d) r = 6, m = 10 for xi = h, f , r, a, n, e, s, y,w, i ; x6 = G in 
Additional file 1: Fig. S5.
Three‑objective GA to maximize the complexity through 
sequence diversity
Among the permutations with overlapping masses 
taken from the examples examined in the previ-
ous section (Fig.  4 and Additional file  1: Figs. S1–S5), 
some entries exhibited different amino acid compo-
sition (Additional file  1: Fig. S7). In order to preserve 
these solutions in the library design, we introduced a 
third fitness function to distinguish the permutations 
by their composition. Consequently, the optimization 
implemented for combinatorial peptide library design 
computed the number of peptides of unique amino acid 
composition and maximized their sequence diversity. 
In addition, the introduction of sequence diversity as a 
fitness function enables the 3-objective GA to find new 
solutions that may have been neglected in the 2-objec-
tive setting because of lower mass diversity. An example 
is a heptapeptide library from the xi = s, e, r,w, a,G, i , 
x3 = p , x7 = y optimization where two permutations 
with different sequence, aGpGery and rGpGisy, show 
monoisotopic masses of 748.3505 and 748.3869, respec-
tively (Additional file 1: Fig. S7). In this particular case, 
the monoisotopic mass of ‘ae’ dipeptide (218.116) over-
laps with the mass of the ‘is’ dipeptide (218.079). These 
two peptides would have been excluded in the previous 
version of the algorithm with T (�mass) = 1 , but now 
they are included because of the increased sequence 
diversity within the library.
Using the 3-objective GA, the optimization results 
are displayed in a three-dimensional Pareto front, from 
which the 2D projections of both amino acid diver-
sity and mass diversity can be extracted and analysed 
separately (Additional file  1: Fig. S6). In addition to 
the output obtained with the 2-objective GA, the out-
put of the 3-objective optimization contains a separate 
csv file listing all the permutations unique by sequence. 
In this setting, we performed the optimization for two 
libraries: r = 5, m = 6 for xi = s, e, r,w, a,G ; x6 = y 
in Fig.  5a–c and r = 5, m = 7 for xi = s, e, r,w, a,G, i ; 
x3 = p , x7 = y in Fig.  5d–f. We analyzed the output 
of these examples showing the difference between 
the sequence and mass diversity of the best solutions, 
followed by the analysis of the 70% to 100% diver-
sity region of all solutions and finally presenting the 
sequence logo graphs of two prominent solutions.
The diversity analysis of the libraries (Fig. 5a, d) con-
sists of a parallel representation of sequence and mass 
diversity distributions on the y-axis for all the best 
solutions, where each has a different total number of 
permutations on the x-axis. In these figures, three dis-
tinct regions can be observed:
1 for smaller library sizes, composed of 200 or less 
permutations, the optimization outputs of mass and 
sequence diversity overlap;
2 for medium sized libraries, containing a 1000 or 
more permutations, the sequence diversity exhibits a 
faster growth than the mass diversity;
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3 for large libraries with more than 2000 permuta-
tions, both diversities saturate and exhibit almost no 
growth with the increase of library size.
The behavior of the optimization results is summarized in 
the optimal solutions graph (Additional file 1: Fig. S6d), 
where two areas of interest are labeled: the overlapping 
zone (1) where the diversity by sequence and by mass is 
very similar, and the diversity zone (2) where the diversity 
by sequence is greater than the diversity by mass. This 
underlines the overall advantage of the introduction of 
the third objective in the optimization process that offers 
a greater possibility to fine-tune the design and fulfill the 
users’ requirements. As expected, the number of peptides 
Fig. 4 Two-objective genetic algorithm-informed design suggestions for experimental validation. a Pareto front (output) of the optimization results 
for the OBOC peptide library having 5 positions where variability was introduced (r = 5), with m = 7 and xi = s, e, r ,w , a,G, i and two fixed positions, 
being x3 = p and x7 = y . In the zoom of the pareto front, in the 70–100% mass diversity range, we chose five best solutions: BS 1 (100%), BS 2 
(98%), BS 3 (86%), BS 4 (77%) and BS 6 (70%). b Sequence logo representation of the BS 2, showing the maximally diverse random peptide library 
design we would choose for further studies. c Sequence logos of BS 1, BS 3, BS 4 and BS 6 suggesting various synthetic possibilities and pointing 
out possible synthetic challenges. Several other design suggestions are available, but we show only these five for simplicity
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unique by sequence is higher than the number of pep-
tides unique by mass, but both numbers have a theoreti-
cal maximum, which is considerably lower than the total 
number of permutations within the library.
Figure  5b, e present the 2D graphs of the best solu-
tions (green dots) alongside all the solutions (blue dots) 
from the optimization representing mass diversity on 
the x-axis and sequence diversity on the y-axis, relative 
to the total number of permutations. This representa-
tion includes an overview of several other design options 
available that might be of interest to the user and could 
lead to highly diverse libraries. We focused our interest to 
the 70% to 100% diversity region and chose only solutions 
of sequence diversity higher than 95% even if their mass 
diversity was lower. Two prominent designs are marked 
and their sequence logo graphs presented in Fig.  5c, f. 
Both the examples show sequence diversity of 98% while 
their diversity by mass is 89% and 81%, respectively. Con-
sidering that the sequence diversity is a stronger indica-
tor of chemical diversity within the library, it is evident 
that these two solutions cover a wide range of chemical 
properties and possibly offer alternative design choices 
worth of consideration.
In the current system, if the user is interested in mak-
ing a hydrophobic library, the input should consist of 
preferentially hydrophobic amino acids. The algorithm-
assisted, three-objective optimization offers different 
possibilities of peptide designs, shown for the high diver-
sity region (70–100%) as well as for the 10–50% diversity 
region, in Additional file 1: Figs. S8 and S9.
Comparison of two‑ and three‑objective settings and the 
effect of T(�mass)
Although the computational cost for the three-objective 
GA optimization is higher, the benefit of increasing the 
sequence diversity is visible when comparing the output 
results, i.e., the best solutions of the 3- and 2-GA opti-
mizations. Figure 6 presents this comparison in the 70% 
to 100% diversity region for two different inputs: (a) 
r = 5, m = 6 and xi = s, e, r,w, a,G ; x6 = y and (b) r = 
5, m = 7 and xi = s, e, r,w, a,G, i ; x3 = p , x7 = y . It can 
be noticed that the best solutions from the 3-objective 
optimization (red crosses) are more numerous than the 
2-objective ones (blue dots), indicating the coverage of a 
larger search space and greater design choices. However, 
the number of solutions with higher diversity is closely 
Fig. 5 Three-objective genetic algorithm-informed design suggestions. a Diversity analysis of all the best solutions obtained by the 3-objective 
optimization for (r = 5, m = 6 for xi = s, e, r ,w , a,G ; x6 = y ) library design in terms of the number of unique permutations (y-axis) and the total 
number of permutations (x-axis), where each solution is represented with the number of permutations unique by sequence (green points) and by 
mass (red points). b 2D Pareto front of the best, i.e., near optimal solutions (green dots) and all the remaining solutions (blue dots) from the final 
generation representing mass diversity (x-axis) and sequence diversity (y-axis) relative to the total number of permutations. c Sequence logo of 
library design encircled in subfigure (b). Despite lower mass diversity (81%), the library design maintains high sequence diversity (98%), making it an 
attractive synthetic possibility. d–f Refer to the optimization results for the r = 5, m = 7 for xi = s, e, r ,w , a,G, i ; x3 = p , x7 = y library design
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related to the chosen value of the tolerance of mass dis-
crimination T (�mass) . As previously mentioned, we 
set this parameter to T (�mass) = 1 to discriminate the 
permutations by mass. Therefore, should a user require 
lower or higher tolerance values, the ratio between the 
number of permutations unique by sequence and unique 
by mass would change accordingly.
As expected, some of the proposed designs overlap in 
both optimizations as shown in Fig. 6a, b. This suggests 
that the choice of the optimization method will depend 
solely on the users’ requirements. When the mass diver-
sity design is sufficient, the 2-objective optimization will 
be the method of choice. Should a user require additional 
design suggestions based on sequence diversity, it can 
opt for the more costly but more informative 3-objective 
method.
Next, we explored the effect of varying the tolerance 
input to values of T < 1 and T > 1 for the optimization 
described in Fig. 4 using both, the two- (Additional file 1: 
Figs. S10–S14) and the three-objective (Figs.  7, 8 and 
Additional file 1: S14) settings. When changing T (�mass) 
to 2, 5, 0.5, 0.1, 0.01 and 0.001, the distribution of best 
solutions (Fig.  7) and the number of permutations for 
related mass diversities are affected (Fig. 8). The impact 
of varying the T (�mass) from 0.001 to 2.5 on the num-
ber of best solutions is visible in the optimization results 
where a smaller tolerance window yields a lower number 
of best solutions. An example is the high diversity region 
(sequence diversity above 90%), where the number of 
best solutions is 10 for T = 0.5, 9 for T = 0.1, 5 for T = 
0.01 and only 4 for T = 0.001 (Fig. 7). In addition, when 
lowering T (�mass) to values close to zero such as 0.001 
and 0.01, the algorithm behaves as sequence diversity was 
the measure of library diversity, i.e. it works according 
to the 3rd objective. This results in mass and sequence 
diversity being linearly correlated as seen in Fig. 7d.
In agreement with the spread of pareto fronts shown in 
Fig. 8, the number of permutations increases for decreas-
ing values of T (�mass) and hence, the pareto front 
shifts to the right accordingly. By comparing best solu-
tions having 85(±1 )% mass diversity (Fig.  8), it can be 
noticed that the number of permutations increases from 
48 (T = 2.5) to 72 (T = 1), 108 (T = 0.5 and T = 0.1), 
144 (T = 0.01) and 162 (T = 0.001). For T (�mass) values 
below 1, i.e., 0.5, 0.1, 0.01 and 0.001, no differences are 
observed in terms of number of library components for 
BS1 (100% diversity). On the other hand, when increasing 
the T (�mass) value to 1 and 2.5, BS 1 (100% diversity) 
shows a decreasing number of library components from 
36 (BS1, T = 1 ) to 32 (BS1, T = 2.5).
Furthermore, in the 2-objective setting, by lower-
ing the tolerance window, the number of permutations 
with unique mass increases, to take into account those 
sequences that have different amino acid composition 
but mass difference lower than T (�mass) . As expected, 
there is little difference in optimization results between 
T (�mass) values of 0.5 and 0.1. In the high diversity 
region BS1, BS2, BS3 and BS5 match while BS 4 shows 
one more peptide unique by mass for T = 0.1 . When 
looking at T = 0.01 , the differences are more pronounced 
in terms of mass diversity and number of library compo-
nents seen for BS 2, BS 3, BS 4 and BS 5 when compared 
to T (�mass) values of 0.5 and 0.1 (Additional file 1: Figs. 
S10–S13).
Conclusions
When dealing with collections of structurally similar 
compounds, such as peptides that have the same amino 
acid composition but differential positioning of residues 
Fig. 6 3-objective versus 2-objective comparison. Parallel 
representation of the best solutions obtained by 2-objective 
(blue dots) and 3-objective (red crosses) optimization marking 
the overlapping solutions (circled) for the same input data in 
terms of mass diversity (x-axis) and sequence diversity (y-axis) 
relative to the total number of permutations for a r = 5, m = 6 and 
xi = s, e, r ,w , a,G ; x6 = y library design and for b r = 5, m = 7 and 
xi = s, e, r ,w , a,G, i ; x3 = p , x7 = y library design
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in the sequence (permutations), similar or identical mass, 
and similar physico-chemical properties, it is challenging 
to discriminate single permutations with high accuracy. 
Therefore, diversity rather than library size is the key ele-
ment when designing random peptide libraries for the 
discovery of novel biologically active peptides.
In this paper, we have presented an algorithm-sup-
ported methodology for the design of random peptide 
libraries. Basing the methodology on the multi-objective 
genetic algorithms we achieved libraries with maximal 
number of peptides that seek to maximal mass and/or 
sequence diversity. In the two-objective setting, where 
the goal was mass diversity, the tolerance parameter 
allows the library designer to define how different two 
peptides should be in terms of their mass. Moreover, 
sequence diversity was achieved in the three-objective 
setting that offered additional library solutions whit 
similar mass but differential composition of amino acids. 
This system could be extended to several other fitness 
functions and their combinations. A possible future 
multi-objective GA could take into account the charge or 
the hydrophobicity/philicity of the library components.
Intelligent systems that operate under controlled con-
ditions allow us to explore huge search spaces and offer 
a large number of possible solutions. It is up to the user 
to choose the solution of interest. Throughout a series of 
examples we highlighted the advantage of having numer-
ous design suggestions before attempting any synthesis of 
complex mixtures. In this way, we could rationally design 
a library or different pools of smaller libraries—having 
desired properties and amino acid compositions—based 
on informed and careful user choices. Thus, this paper 
demonstrated the necessity of interlinking the advanced 
computing capabilities of genetic algorithms and the 
design of peptide libraries. The size of the search space 
makes heuristic algorithms the method of choice. In fact, 
the range of possible solutions is difficult to access to an 
expert user even for smaller scale inputs.
Fig. 7 The effect of varying T (�mass) on the distribution of best solutions. The analysis of mass diversity (x-axis) and sequence diversity (y-axis) 
of the best, i.e., near optimal solutions (green dots) and all the remaining solutions (blue dots) is given for a T (�mass) = 0.5 , b T (�mass) = 0.1 , c 
T (�mass) = 0.01 and d T (�mass) = 0.001
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Materials and methods
The definition of input parameters is presented in Algo-
rithm 1, where r is the number of positions, counter is the 
number of amino acids at each position and full list is the 
full amino acid list:
Input: r








Algorithm 1: Input parameters
The core NSGA-II algorithm is used from the Mat-
lab built-in script gamultiobj. Its default parameters are 
modified as follows:
• ‘PopulationSize’ is set to 500,
• ‘ParetoFraction’ is set to 0.2,
• ‘PopulationType’ is set to ‘bitstring’.
The binary encoded genome for NSGA-II is created 
as a bit-string of length:
The methodology used to compute the three fitness func-
tions ( FF1 , FF2 and FF3 ) for each Genome is presented 
graphically in Fig. 9.
Algorithm  2 (readGenome) is used to transform the 
genome of a solution obtained by NSGA-II into a algo-






Fig. 8 The effect of varying T (�mass) on the number of permutations. a Parallel representation of pareto fronts in the 70–100% diversity range, for 
T (�mass) ∈ {2.5, 1, 0.5, 0.1, 0.01, 0.001} obtained by the 3-objective optimizations for (r = 5, m = 7 and xi = s, e, r ,w , a,G, i ; x3 = p , x7 = y ) library 
design, where each optimization run is presented in different color. b Sequence logos of library designs encircled in subfigure a 
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Input: genome
Input: full list [][]
Input: r
for i: 1 → r do
k = 1;
for j: 1 → counter[i] do
if genome [i][j] == TRUE then
selected list [i][k] = full list [i][j];
k++;
else






The analysis of the library solution (selected_list) is fol-
lowed by the computation of the permutations which 
constitute the Library. Algorithm permutations uses 
Matlab built-in function ndgrid to make the computation.
Algorithm (getMass) is used to compute the mass of 
every permutation within the Library using the following 
equation:
where M represents the mass of a peptide, m(ai) repre-
sents the mass of amino acid a at position i within the 








− (r − 1) ·m(H2O)
Slightly modifying the Eq. 2, the algorithm computes the 
average mass, the monoisotopic mass, the singly charged 
[M +H ]+ or the doubly charged [M + 2H ]2+ mass of 
peptides.
The analysis of the Library is followed by the exclu-




Unique by mass = Library;
for i: 1 → length(Library) do
find j where |Mi −Mj | < T (∆mass) (i = j)
Unique by mass[j] = [];
end
Output: Unique by mass
Algorithm 3: Exclude similar mass
where Mi and Mj are masses of permutations at positions 
i and j within the Library, while T (�mass) is the toler-
ance of mass discrimination. If the absolute value of mass 
difference between permutations at positions i and j is 
less than T (�mass) , then the permutation at position j is 
removed from the Library list. Algorithm Exclude similar 
mass repeats this process until all the permutations are 
compared and only the ones with unique mass remain in 
the list (Unique by mass).
The analysis of the Library is also followed by the 
exclusion of peptides of equal sequence implemented 
in Algorithm 4:
Fig. 9 Schematic representation of the computation of 3 objectives within the NSGA-II 
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Input: Library
Mass = getMass(Library);
sort: Library by Mass;
Unique by sequence = Library;
for i: 1 → length(Library) do
j = i + 1;
while |Mi −Mj | < T (∆mass) do
if sort(char(Library[i])) ==
sort(char(Library[j])) then





Output: Unique by sequence
Algorithm 4: Exclude equal sequence
The algorithm Exclude equal sequence uses the algo-
rithm getMass to speed up the search because pep-
tides of similar mass are candidates for peptides of 
equal sequence. The candidate permutations within the 
Library need to be transformed into a list of characters 
and sorted alphabetically. If two peptides have equal list 
of sorted characters, one of them is excluded from the 
Library list. Algorithm Exclude equal sequence repeats 
this process until all the permutations are compared and 
only the ones with unique sequence remain in the list 
(Unique by sequence).
Additional files
Additional file 1. Supporting information for Algorithm-supported, mass 
and sequence diversity-oriented random peptide library design
Additional file 2. List of amino acid permutations for BS 2, from the 
optimization in Fig. 4.
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